Elisabetta Argenzio PhD

EMBO Journal

Elisabetta received her PhD from the European School of Molecular Medicine (SEMM) in Milan where she studied the role of ubiquitination in EGF receptor signalling and endocytosis in the labs of Simona Polo and Pier Paolo Di Fiore. In 2009, she joined Wouter Moolenaar’s group at The Netherlands Cancer Institute in Amsterdam for her post-doctoral work on the regulation of integrin trafficking and signalling by lipid growth factors and intracellular chloride channels. Subsequently, she got interested in translational cancer research and moved to the laboratory of Marcel Verheij as senior postdoctoral fellow to characterise the uptake of antitumor alkyl-lysophospholipid drugs in cancer cells. Elisabetta joined The EMBO Journal in 2017 and is responsible for the areas of autophagy & cell death, membranes & intracellular transport and metabolism.